The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-01

AUTHORS

Jitsuo Higaki, Issei Komuro, Kosuke Shiki, Hiroyuki Ugai, Atsushi Taniguchi, Hiroshi Ikeda, Daisuke Kuroki, Seiichiro Nishimura, Toshio Ogihara

ABSTRACT

The aim of this study was to compare 80 mg telmisartan/5 mg amlodipine/12.5 mg hydrochlorothiazide (T80/A5/H12.5) with 80 mg telmisartan/12.5 mg hydrochlorothiazide (T80/H12.5) to determine their relative blood pressure (BP) lowering effects in essential hypertensive patients with inadequate control and to evaluate the long-term safety of T80/A5/H12.5 in a 52-week extension period. Patients (n=132) were randomly assigned to receive double-blind treatment with T80/A5/H12.5 or T80/H12.5 for 8 weeks after a 6-week run-in-period of T80/H12.5. All 126 patients who completed the double-blind period entered the 52-week open-label extension and received T80/A5/H12.5. The adjusted mean changes from the reference baseline of the trough-seated systolic and diastolic BP (SBP/DBP) at week 8 were significantly larger in the T80/A5/H12.5 group (-10.6/-8.8 mm Hg) than in the T80/H12.5 group (-2.3/-1.3 mm Hg) (P<0.0001). The BP-lowering effect of T80/A5/H12.5 was maintained over the 52-week extension period. The adverse events (AEs) during both treatment periods were generally mild. Drug-related AEs were reported in one patient in each group in the double-blind period and in five patients exposed to T80/A5/H12.5 in the double-blind and/or open-label extension period. T80/A5/H12.5 therapy was clinically and statistically superior to T80/H12.5 therapy for the reduction of BP in patients with essential hypertension uncontrolled with T80/H12.5, and its BP-lowering effect was maintained in the long term. T80/A5/H12.5 was generally well-tolerated. More... »

PAGES

51

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/hr.2016.100

DOI

http://dx.doi.org/10.1038/hr.2016.100

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1013989501

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27581533


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amlodipine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzimidazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzoates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Essential Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydrochlorothiazide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Japan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Telmisartan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Ehime University", 
          "id": "https://www.grid.ac/institutes/grid.255464.4", 
          "name": [
            "Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine, Ehime, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Higaki", 
        "givenName": "Jitsuo", 
        "id": "sg:person.01144702071.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144702071.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Komuro", 
        "givenName": "Issei", 
        "id": "sg:person.01012024207.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012024207.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Boehringer Ingelheim (Japan)", 
          "id": "https://www.grid.ac/institutes/grid.459839.a", 
          "name": [
            "Medical Division, Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shiki", 
        "givenName": "Kosuke", 
        "id": "sg:person.012510377655.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012510377655.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Boehringer Ingelheim (Japan)", 
          "id": "https://www.grid.ac/institutes/grid.459839.a", 
          "name": [
            "Medical Division, Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ugai", 
        "givenName": "Hiroyuki", 
        "id": "sg:person.01137367331.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137367331.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Boehringer Ingelheim (Japan)", 
          "id": "https://www.grid.ac/institutes/grid.459839.a", 
          "name": [
            "Medical Division, Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taniguchi", 
        "givenName": "Atsushi", 
        "id": "sg:person.01025541307.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025541307.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Boehringer Ingelheim (Japan)", 
          "id": "https://www.grid.ac/institutes/grid.459839.a", 
          "name": [
            "Medical Division, Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ikeda", 
        "givenName": "Hiroshi", 
        "id": "sg:person.014700721255.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014700721255.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Boehringer Ingelheim (Japan)", 
          "id": "https://www.grid.ac/institutes/grid.459839.a", 
          "name": [
            "Medical Division, Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuroki", 
        "givenName": "Daisuke", 
        "id": "sg:person.015476301655.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015476301655.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Boehringer Ingelheim (Japan)", 
          "id": "https://www.grid.ac/institutes/grid.459839.a", 
          "name": [
            "Medical Division, Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nishimura", 
        "givenName": "Seiichiro", 
        "id": "sg:person.016273662255.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016273662255.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Morinomiya University of Medical Sciences", 
          "id": "https://www.grid.ac/institutes/grid.440914.c", 
          "name": [
            "Morinomiya University of Medical Sciences, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ogihara", 
        "givenName": "Toshio", 
        "id": "sg:person.01174620432.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174620432.33"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/hr.2012.87", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002410002", 
          "https://doi.org/10.1038/hr.2012.87"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1253/circj.cj-13-0847", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006031856"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2015.3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006326583", 
          "https://doi.org/10.1038/hr.2015.3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2015.3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006326583", 
          "https://doi.org/10.1038/hr.2015.3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.108.790048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011179583"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.14740/jocmr2292w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019341947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1470320312439493", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034950912"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1470320312439493", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034950912"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40292-014-0041-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036129922", 
          "https://doi.org/10.1007/s40292-014-0041-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjmed.2006.08.033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037450962"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(11)61055-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039574355"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/hypertensionaha.109.139816", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041011472"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/hypertensionaha.109.139816", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041011472"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2013.80", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041803518", 
          "https://doi.org/10.1038/hr.2013.80"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2013.80", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041803518", 
          "https://doi.org/10.1038/hr.2013.80"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2013.80", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041803518", 
          "https://doi.org/10.1038/hr.2013.80"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2013.19", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042231993", 
          "https://doi.org/10.1038/hr.2013.19"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2014.20", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044401479", 
          "https://doi.org/10.1038/hr.2014.20"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/03007995.2015.1098598", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046981632"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4236/ojim.2012.22014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049726525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/strokeaha.110.611566", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050121970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/strokeaha.110.611566", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050121970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18203/2320-6012.ijrms20150291", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068581345"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18203/2320-6012.ijrms20150291", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068581345"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7860/jcdr/2015/14054.6366", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074082109"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-01", 
    "datePublishedReg": "2017-01-01", 
    "description": "The aim of this study was to compare 80\u2009mg telmisartan/5\u2009mg amlodipine/12.5\u2009mg hydrochlorothiazide (T80/A5/H12.5) with 80\u2009mg telmisartan/12.5\u2009mg hydrochlorothiazide (T80/H12.5) to determine their relative blood pressure (BP) lowering effects in essential hypertensive patients with inadequate control and to evaluate the long-term safety of T80/A5/H12.5 in a 52-week extension period. Patients (n=132) were randomly assigned to receive double-blind treatment with T80/A5/H12.5 or T80/H12.5 for 8 weeks after a 6-week run-in-period of T80/H12.5. All 126 patients who completed the double-blind period entered the 52-week open-label extension and received T80/A5/H12.5. The adjusted mean changes from the reference baseline of the trough-seated systolic and diastolic BP (SBP/DBP) at week 8 were significantly larger in the T80/A5/H12.5 group (-10.6/-8.8\u2009mm\u2009Hg) than in the T80/H12.5 group (-2.3/-1.3\u2009mm\u2009Hg) (P<0.0001). The BP-lowering effect of T80/A5/H12.5 was maintained over the 52-week extension period. The adverse events (AEs) during both treatment periods were generally mild. Drug-related AEs were reported in one patient in each group in the double-blind period and in five patients exposed to T80/A5/H12.5 in the double-blind and/or open-label extension period. T80/A5/H12.5 therapy was clinically and statistically superior to T80/H12.5 therapy for the reduction of BP in patients with essential hypertension uncontrolled with T80/H12.5, and its BP-lowering effect was maintained in the long term. T80/A5/H12.5 was generally well-tolerated.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/hr.2016.100", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1313717", 
        "issn": [
          "0916-9636", 
          "1348-4214"
        ], 
        "name": "Hypertension Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "40"
      }
    ], 
    "name": "The efficacy and long-term safety of a triple combination of 80\u2009mg telmisartan, 5\u2009mg amlodipine and 12.5\u2009mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension", 
    "pagination": "51", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "42a490a958ec925e3de2eae4b7e67bcc98dddec4b2c8c6989c38255e55056cd5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27581533"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9307690"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/hr.2016.100"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1013989501"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/hr.2016.100", 
      "https://app.dimensions.ai/details/publication/pub.1013989501"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000346_0000000346/records_99806_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/hr2016100"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/hr.2016.100'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/hr.2016.100'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/hr.2016.100'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/hr.2016.100'


 

This table displays all metadata directly associated to this object as RDF triples.

270 TRIPLES      21 PREDICATES      66 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/hr.2016.100 schema:about N06b8df0f657a4fbf88a012a222252bc5
2 N0ccc7af86f9c498aa86428569e420941
3 N157c443098d243e98da4ed54dd1910be
4 N24839f5376ae4f6ead8060f6a3e3a15e
5 N330da646e815478fa2086ee67391af02
6 N3eb0dc05ec494d758c469539073257c9
7 N5c96f77b73ee41d982cf931cb218b7ef
8 N78ec3d555dd44d8297f18b613060871e
9 N84c028eef2054441892970df37169e93
10 N8f395020cead4be088f708a8ca51d7af
11 N92bfef824de74a86a0463dd46046541c
12 N93190ab5ab684764a5a286f40d84bc35
13 N979ced3af0f6477c97e46d11f8405d8d
14 Na8ae4d69774f40a4bf76214ab869581e
15 Nd4494a77dcf8423a983f32e653f3cca7
16 Nd9d9f0c5dac44c2b931c2e03b8abea73
17 Ne047b720216747d4864a7ce819156916
18 Ne3aa172a54dd472f84f00df153dc7b5a
19 Nef9451990e1b4d50af232135dae721b6
20 anzsrc-for:11
21 anzsrc-for:1102
22 schema:author N52d7588091ba450eb2c2e3613f3a5b36
23 schema:citation sg:pub.10.1007/s40292-014-0041-8
24 sg:pub.10.1038/hr.2012.87
25 sg:pub.10.1038/hr.2013.19
26 sg:pub.10.1038/hr.2013.80
27 sg:pub.10.1038/hr.2014.20
28 sg:pub.10.1038/hr.2015.3
29 https://doi.org/10.1016/j.amjmed.2006.08.033
30 https://doi.org/10.1016/s0140-6736(11)61055-6
31 https://doi.org/10.1161/circulationaha.108.790048
32 https://doi.org/10.1161/hypertensionaha.109.139816
33 https://doi.org/10.1161/strokeaha.110.611566
34 https://doi.org/10.1177/1470320312439493
35 https://doi.org/10.1185/03007995.2015.1098598
36 https://doi.org/10.1253/circj.cj-13-0847
37 https://doi.org/10.14740/jocmr2292w
38 https://doi.org/10.18203/2320-6012.ijrms20150291
39 https://doi.org/10.4236/ojim.2012.22014
40 https://doi.org/10.7860/jcdr/2015/14054.6366
41 schema:datePublished 2017-01
42 schema:datePublishedReg 2017-01-01
43 schema:description The aim of this study was to compare 80 mg telmisartan/5 mg amlodipine/12.5 mg hydrochlorothiazide (T80/A5/H12.5) with 80 mg telmisartan/12.5 mg hydrochlorothiazide (T80/H12.5) to determine their relative blood pressure (BP) lowering effects in essential hypertensive patients with inadequate control and to evaluate the long-term safety of T80/A5/H12.5 in a 52-week extension period. Patients (n=132) were randomly assigned to receive double-blind treatment with T80/A5/H12.5 or T80/H12.5 for 8 weeks after a 6-week run-in-period of T80/H12.5. All 126 patients who completed the double-blind period entered the 52-week open-label extension and received T80/A5/H12.5. The adjusted mean changes from the reference baseline of the trough-seated systolic and diastolic BP (SBP/DBP) at week 8 were significantly larger in the T80/A5/H12.5 group (-10.6/-8.8 mm Hg) than in the T80/H12.5 group (-2.3/-1.3 mm Hg) (P<0.0001). The BP-lowering effect of T80/A5/H12.5 was maintained over the 52-week extension period. The adverse events (AEs) during both treatment periods were generally mild. Drug-related AEs were reported in one patient in each group in the double-blind period and in five patients exposed to T80/A5/H12.5 in the double-blind and/or open-label extension period. T80/A5/H12.5 therapy was clinically and statistically superior to T80/H12.5 therapy for the reduction of BP in patients with essential hypertension uncontrolled with T80/H12.5, and its BP-lowering effect was maintained in the long term. T80/A5/H12.5 was generally well-tolerated.
44 schema:genre research_article
45 schema:inLanguage en
46 schema:isAccessibleForFree true
47 schema:isPartOf N92f9f71b58894325b9b5290960ff6d51
48 Nfad81c9adb904b0b9a259b9cc09bec0f
49 sg:journal.1313717
50 schema:name The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension
51 schema:pagination 51
52 schema:productId N24ff6cc5738c46bdb6ddaa8cb0719921
53 N3cf72b55d4f24ff2bfd31b16f2b104e0
54 Nb86ca1b111a141b982efab97865975fa
55 Ndf9b9cd02266401b9fd7049fa27fed60
56 Nefccc58834524b74be8fe3f9ff243f64
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013989501
58 https://doi.org/10.1038/hr.2016.100
59 schema:sdDatePublished 2019-04-11T09:31
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher N11da8f2329874e4f964a08af361ad82e
62 schema:url https://www.nature.com/articles/hr2016100
63 sgo:license sg:explorer/license/
64 sgo:sdDataset articles
65 rdf:type schema:ScholarlyArticle
66 N06b8df0f657a4fbf88a012a222252bc5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Treatment Outcome
68 rdf:type schema:DefinedTerm
69 N0ccc7af86f9c498aa86428569e420941 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Benzimidazoles
71 rdf:type schema:DefinedTerm
72 N118ed779608646b882bfeeb61b4a4204 rdf:first sg:person.01012024207.33
73 rdf:rest N168e82850240431a8b814e91fb39b50c
74 N11da8f2329874e4f964a08af361ad82e schema:name Springer Nature - SN SciGraph project
75 rdf:type schema:Organization
76 N157c443098d243e98da4ed54dd1910be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Antihypertensive Agents
78 rdf:type schema:DefinedTerm
79 N158e7eb50e314ae1a9b278e112f9f739 rdf:first sg:person.014700721255.60
80 rdf:rest N816a080ade524061ba4db7228bb11c59
81 N168e82850240431a8b814e91fb39b50c rdf:first sg:person.012510377655.63
82 rdf:rest N212446891c694e648fb287745ac8aa65
83 N1aea0060df244a99a314d5dc57cecb76 rdf:first sg:person.01174620432.33
84 rdf:rest rdf:nil
85 N212446891c694e648fb287745ac8aa65 rdf:first sg:person.01137367331.18
86 rdf:rest N66785c578d614657ba00c1a6f44fd62b
87 N24839f5376ae4f6ead8060f6a3e3a15e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Middle Aged
89 rdf:type schema:DefinedTerm
90 N24ff6cc5738c46bdb6ddaa8cb0719921 schema:name dimensions_id
91 schema:value pub.1013989501
92 rdf:type schema:PropertyValue
93 N330da646e815478fa2086ee67391af02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Double-Blind Method
95 rdf:type schema:DefinedTerm
96 N3cf72b55d4f24ff2bfd31b16f2b104e0 schema:name readcube_id
97 schema:value 42a490a958ec925e3de2eae4b7e67bcc98dddec4b2c8c6989c38255e55056cd5
98 rdf:type schema:PropertyValue
99 N3dc6b258912949f18a7c2035eee8774d rdf:first sg:person.016273662255.16
100 rdf:rest N1aea0060df244a99a314d5dc57cecb76
101 N3eb0dc05ec494d758c469539073257c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Drug Therapy, Combination
103 rdf:type schema:DefinedTerm
104 N52d7588091ba450eb2c2e3613f3a5b36 rdf:first sg:person.01144702071.12
105 rdf:rest N118ed779608646b882bfeeb61b4a4204
106 N5c96f77b73ee41d982cf931cb218b7ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Japan
108 rdf:type schema:DefinedTerm
109 N66785c578d614657ba00c1a6f44fd62b rdf:first sg:person.01025541307.58
110 rdf:rest N158e7eb50e314ae1a9b278e112f9f739
111 N78ec3d555dd44d8297f18b613060871e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Hypertension
113 rdf:type schema:DefinedTerm
114 N816a080ade524061ba4db7228bb11c59 rdf:first sg:person.015476301655.72
115 rdf:rest N3dc6b258912949f18a7c2035eee8774d
116 N84c028eef2054441892970df37169e93 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Hydrochlorothiazide
118 rdf:type schema:DefinedTerm
119 N8f395020cead4be088f708a8ca51d7af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Telmisartan
121 rdf:type schema:DefinedTerm
122 N92bfef824de74a86a0463dd46046541c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Aged
124 rdf:type schema:DefinedTerm
125 N92f9f71b58894325b9b5290960ff6d51 schema:issueNumber 1
126 rdf:type schema:PublicationIssue
127 N93190ab5ab684764a5a286f40d84bc35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Male
129 rdf:type schema:DefinedTerm
130 N979ced3af0f6477c97e46d11f8405d8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Essential Hypertension
132 rdf:type schema:DefinedTerm
133 Na8ae4d69774f40a4bf76214ab869581e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Humans
135 rdf:type schema:DefinedTerm
136 Nb86ca1b111a141b982efab97865975fa schema:name pubmed_id
137 schema:value 27581533
138 rdf:type schema:PropertyValue
139 Nd4494a77dcf8423a983f32e653f3cca7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Female
141 rdf:type schema:DefinedTerm
142 Nd9d9f0c5dac44c2b931c2e03b8abea73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Adult
144 rdf:type schema:DefinedTerm
145 Ndf9b9cd02266401b9fd7049fa27fed60 schema:name nlm_unique_id
146 schema:value 9307690
147 rdf:type schema:PropertyValue
148 Ne047b720216747d4864a7ce819156916 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Amlodipine
150 rdf:type schema:DefinedTerm
151 Ne3aa172a54dd472f84f00df153dc7b5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Blood Pressure
153 rdf:type schema:DefinedTerm
154 Nef9451990e1b4d50af232135dae721b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Benzoates
156 rdf:type schema:DefinedTerm
157 Nefccc58834524b74be8fe3f9ff243f64 schema:name doi
158 schema:value 10.1038/hr.2016.100
159 rdf:type schema:PropertyValue
160 Nfad81c9adb904b0b9a259b9cc09bec0f schema:volumeNumber 40
161 rdf:type schema:PublicationVolume
162 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
163 schema:name Medical and Health Sciences
164 rdf:type schema:DefinedTerm
165 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
166 schema:name Cardiorespiratory Medicine and Haematology
167 rdf:type schema:DefinedTerm
168 sg:journal.1313717 schema:issn 0916-9636
169 1348-4214
170 schema:name Hypertension Research
171 rdf:type schema:Periodical
172 sg:person.01012024207.33 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
173 schema:familyName Komuro
174 schema:givenName Issei
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012024207.33
176 rdf:type schema:Person
177 sg:person.01025541307.58 schema:affiliation https://www.grid.ac/institutes/grid.459839.a
178 schema:familyName Taniguchi
179 schema:givenName Atsushi
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025541307.58
181 rdf:type schema:Person
182 sg:person.01137367331.18 schema:affiliation https://www.grid.ac/institutes/grid.459839.a
183 schema:familyName Ugai
184 schema:givenName Hiroyuki
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137367331.18
186 rdf:type schema:Person
187 sg:person.01144702071.12 schema:affiliation https://www.grid.ac/institutes/grid.255464.4
188 schema:familyName Higaki
189 schema:givenName Jitsuo
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144702071.12
191 rdf:type schema:Person
192 sg:person.01174620432.33 schema:affiliation https://www.grid.ac/institutes/grid.440914.c
193 schema:familyName Ogihara
194 schema:givenName Toshio
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174620432.33
196 rdf:type schema:Person
197 sg:person.012510377655.63 schema:affiliation https://www.grid.ac/institutes/grid.459839.a
198 schema:familyName Shiki
199 schema:givenName Kosuke
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012510377655.63
201 rdf:type schema:Person
202 sg:person.014700721255.60 schema:affiliation https://www.grid.ac/institutes/grid.459839.a
203 schema:familyName Ikeda
204 schema:givenName Hiroshi
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014700721255.60
206 rdf:type schema:Person
207 sg:person.015476301655.72 schema:affiliation https://www.grid.ac/institutes/grid.459839.a
208 schema:familyName Kuroki
209 schema:givenName Daisuke
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015476301655.72
211 rdf:type schema:Person
212 sg:person.016273662255.16 schema:affiliation https://www.grid.ac/institutes/grid.459839.a
213 schema:familyName Nishimura
214 schema:givenName Seiichiro
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016273662255.16
216 rdf:type schema:Person
217 sg:pub.10.1007/s40292-014-0041-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036129922
218 https://doi.org/10.1007/s40292-014-0041-8
219 rdf:type schema:CreativeWork
220 sg:pub.10.1038/hr.2012.87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002410002
221 https://doi.org/10.1038/hr.2012.87
222 rdf:type schema:CreativeWork
223 sg:pub.10.1038/hr.2013.19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042231993
224 https://doi.org/10.1038/hr.2013.19
225 rdf:type schema:CreativeWork
226 sg:pub.10.1038/hr.2013.80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041803518
227 https://doi.org/10.1038/hr.2013.80
228 rdf:type schema:CreativeWork
229 sg:pub.10.1038/hr.2014.20 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044401479
230 https://doi.org/10.1038/hr.2014.20
231 rdf:type schema:CreativeWork
232 sg:pub.10.1038/hr.2015.3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006326583
233 https://doi.org/10.1038/hr.2015.3
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1016/j.amjmed.2006.08.033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037450962
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1016/s0140-6736(11)61055-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039574355
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1161/circulationaha.108.790048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011179583
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1161/hypertensionaha.109.139816 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041011472
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1161/strokeaha.110.611566 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050121970
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1177/1470320312439493 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034950912
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1185/03007995.2015.1098598 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046981632
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1253/circj.cj-13-0847 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006031856
250 rdf:type schema:CreativeWork
251 https://doi.org/10.14740/jocmr2292w schema:sameAs https://app.dimensions.ai/details/publication/pub.1019341947
252 rdf:type schema:CreativeWork
253 https://doi.org/10.18203/2320-6012.ijrms20150291 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068581345
254 rdf:type schema:CreativeWork
255 https://doi.org/10.4236/ojim.2012.22014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049726525
256 rdf:type schema:CreativeWork
257 https://doi.org/10.7860/jcdr/2015/14054.6366 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074082109
258 rdf:type schema:CreativeWork
259 https://www.grid.ac/institutes/grid.255464.4 schema:alternateName Ehime University
260 schema:name Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine, Ehime, Japan
261 rdf:type schema:Organization
262 https://www.grid.ac/institutes/grid.26999.3d schema:alternateName University of Tokyo
263 schema:name Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
264 rdf:type schema:Organization
265 https://www.grid.ac/institutes/grid.440914.c schema:alternateName Morinomiya University of Medical Sciences
266 schema:name Morinomiya University of Medical Sciences, Osaka, Japan
267 rdf:type schema:Organization
268 https://www.grid.ac/institutes/grid.459839.a schema:alternateName Boehringer Ingelheim (Japan)
269 schema:name Medical Division, Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan
270 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...